Research Article
Efficacy and Safety of Lianhuaqingwen Capsules for the Prevention of Coronavirus Disease 2019: A Prospective Open-Label Controlled Trial
Table 8
Proportion of asymptomatically infected subjects with positive nucleic acid tests.
| Follow-up timepoint | Symptomaticity | N = 13 | value | LH group (N = 3) | Control group (N = 10) |
| Isolation period | Asymptomatic infection, N (%) | 3 (100.00) | 9 (90.00) | 1.0000 | Symptomatic infection, N (%) | 0 (0.00) | 1 (10.00) | |
|
|